WIREDGOV

Summary

In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 19 December 2017.

Download as PDF

• English (en)

Table of contents

• Introduction
• Information collection process
• Information required by Article 5.2 of the Council Decision
• Information from the EMA (Article 5.3 of the Council Decision)
• Conclusion
• References